Evidence Hub

Melioidosis in Sickle Cell Hemoglobinopathies in Eastern India: Cavitating Pneumonia and Immune Susceptibility - A Case Series-Based Insight

Prasanta Raghab Moahaptra, Aneri Parekh, B. Behera, Siddarth Singh, S. De

Indian Journal of Medical Microbiology, 2026

Abstract

Melioidosis, caused by Burkholderia pseudomallei, is an emerging infection in the tropics. Most of the melioidosis patients have underlying co-morbidities or occupational exposures. Hemoglobinopathies, such as thalassemia, are established risk factors for melioidosis; however, the association of SCD with melioidosis is infrequently reported. We report two culture-confirmed melioidosis cases from eastern India: a 58-year-old male with SCD on hydroxyurea and another 44-year-old with sickle cell trait, both presenting with cavitary lung lesions mimicking tuberculosis. SCD-related functional asplenia may heighten susceptibility. These cases emphasise the need for clinical vigilance in endemic areas and further research into SCD/SCT-associated immune vulnerabilities.

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free